June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Assessing peripapillary surface macrophage density in eyes with glaucomatous damage using enface OCT
Author Affiliations & Notes
  • Toco Yuen Ping Chui
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Maria Virginia Castanos Toral
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Davis B. Zhou
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Oscar Otero-Marquez
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Justin V Migacz
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Rachel E Linderman
    Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Joseph Carroll
    Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
    Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Donald C Hood
    Department of Psychology, Columbia University, New York, New York, United States
    Department of Ophthalmology, Columbia University, New York, New York, United States
  • Robert Ritch
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
  • Richard B Rosen
    Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, United States
    Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Footnotes
    Commercial Relationships   Toco Chui, None; Maria Castanos Toral, None; Davis Zhou, None; Oscar Otero-Marquez, None; Justin Migacz, None; Rachel Linderman, Optovue (C); Joseph Carroll, Optovue (F); Donald Hood, None; Robert Ritch, C-MER (C), Diopsys Inc (C), Emerald Bioscience Inc (C), Glauconix Inc (C), Guardion Health Sciences (C), Guardion Health Sciences (P), Guardion Health Sciences (I), Intelon Optics (C), Ocular Instruments Inc (P), Sanoculis (C), Sensimed (C), Xoma (C); Richard Rosen, Astellas (C), Bayer (C), Boehringer-Ingelheim (C), Genentech-Roche (C), GlaucoHealth (I), Guardion (I), NanoRetina (C), OD-OS (C), Opticology (I), OptoVue (C), OptoVue (P), Regeneron (C), Teva (C)
  • Footnotes
    Support  This study was supported by the National Eye Institute of the National Institutes of Health under award numbers R01EY027301 and R01EY024969. Additional funding for this research was provided by the Marrus Family Foundation and the New York Eye & Ear Foundation.
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 29. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Toco Yuen Ping Chui, Maria Virginia Castanos Toral, Davis B. Zhou, Oscar Otero-Marquez, Justin V Migacz, Rachel E Linderman, Joseph Carroll, Donald C Hood, Robert Ritch, Richard B Rosen; Assessing peripapillary surface macrophage density in eyes with glaucomatous damage using enface OCT. Invest. Ophthalmol. Vis. Sci. 2021;62(8):29.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To detect and quantify peripapillary surface macrophage density changes in patients with open angle glaucoma (OAG) using enface OCT-reflectance (OCT-R) images.

Methods : 27 controls and 12 moderate to severe OAG patients were imaged using a clinical SDOCT system (Avanti RTVue-XR; Optovue). Ten 4.5x4.5mm scans centered at the optic nerve head (ONH) were obtained and averaged (PMID: 32574351). Seven eyes of 6 OAG patients were imaged at two visits 11-29 months apart. Semi-automated macrophage cell identification was performed on a 3 µm OCT-R slab located between 3 and 6 µm above the ILM using MATLAB (PMID: 32574351). An annular ROI with 0.75mm in width centered at the ONH was created on the OCT-R image (PMID: 29795576) (Fig). This annular ROI was then divided into four quadrants (temporal, nasal, superior and inferior) for macrophage density measurements. Cell density maps were also generated for each subject to allow rapid visualization of cell distribution across the ONH area. Axial length was obtained for ocular magnification correction of each image.

Results : In control eyes, the highest cell density was found in the temporal quadrant with mean±SD of 35.7±12.6 cells/mm2 followed by the nasal (23.4±7.3 cells/mm2), inferior (23.1±7.6 cells/mm2), and superior (22.9±9.4 cells/mm2). In the OAG eyes, the highest cell density was found in the temporal quadrant with mean±SD of 16.6±13.2 cells/mm2 followed by the nasal (15.6±8.3 cells/mm2), superior (12.6±4.8 cells/mm2), and inferior (9.9±6.3 cells/mm2). Cell densities measured at 4 quadrants were significantly reduced in eyes with OAG (Mann-Whitney rank tests, P values <0.05). Focal loss of surface macrophages was observed at regions with retinal nerve fiber bundle (RNFB) defect progression in OAG eyes (Fig). Density mapping of peripapillary surface macrophages enabled us to quantitatively and visually identify this novel feature of progressive RNFB defects.

Conclusions : Clinical OCT is capable of imaging surface macrophages on the ILM in control and glaucoma eyes. Density of these cells appeared reduced in regions with glaucomatous damage. Characterizing the relationship between surface macrophage density and the underlying retinal nerve fiber integrity may be a useful biomarker for active disease progression, and possibly response to treatment.

This is a 2021 ARVO Annual Meeting abstract.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×